Table 2. Fungal infections in patients after augmentation mammoplasty previously reported.
Species | No. of cases | Country reported | Duration (mammoplasty to infection) | Implant removal | Antifungal therapy | Reference |
Candida albicans | 1 | Italy | 3 years | No | Caspofungin | [25] |
Candida albicans | 1 | Turkey | 5 years | Yes | Not specified | [32] |
Candida albicans | 1 | US | 4 years | Yes | Fluconazole | [29] |
Candida albicans | 1 | US | 10 months | Yes | Not specified | [34] |
Candida parapsilosis | 1 | US | 16 days | Yes | Fluconazole | [26] |
Trichosporon beigelii | 1 | US | 16 months | No | Fluconazole | [30] |
Trichosporon spp. | 1 | Singapore | 17 months | No | Fluconazole | [33] |
Aspergillus flavus | 1 | UK | 18 months | Yes | Not specified | [36] |
Aspergillus flavus | 1 | US | 4 years | Yes | Not specified | [31] |
Aspergillus niger | 1 | UK | 5 years | Yes | Not specified | [24] |
Aspergillus niger | 1 | US | Several months | Yes | Not specified | [35] |
Curvularia spp. | 5 | US | 4–12 months | Not specified | Not specified | [27] |
Curvularia spp. | 1 | US | 6 months | Yes | Not specified | [34] |
Paecilomyces variotii | 1 | US | 14 months | Yes | Not specified | [37] |
Penicillium | 3 | US | Not stated | Not specified | Not specified | [28] |